BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6120908)

  • 1. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
    Muechler EK; Kohler D; Huang KE
    Int J Fertil; 1981; 26(4):273-8. PubMed ID: 6120908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
    Tippet PD; Simon JA; Rifka SM; Falk RJ
    Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma estrogen monitoring of ovulation induction.
    Wu CH
    Obstet Gynecol; 1975 Sep; 46(3):294-8. PubMed ID: 1172219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
    Notation AD; Tagatz GE; Steffes MW
    Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A; David H; Libal Y; Ballas S
    Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-ovulatory plasma levels of 17beta-oestradiol (E2) and conception in patients treated with gonadotrophins.
    Ferin J; Thomas K; De Hertogh R
    Acta Endocrinol Suppl (Copenh); 1977; 214():33-42. PubMed ID: 268747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in sterility therapy. Gonadotropin treatment, monitoring follicle maturation using real-time ultrasonics].
    Schmidt W; von Holst T
    Fortschr Med; 1981 Jul; 99(27-28):1080-6. PubMed ID: 6790397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of serum progesterone levels at the time of hCG on the release of ova during hMG cycles.
    Check JH; Adelson HG; Stern J; Lauer C
    Int J Fertil; 1992; 37(2):103-5. PubMed ID: 1349590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
    Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K
    Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulation induction with human menopausal gonadotrophins: an evaluation of a variable daily dosage regimen.
    Webb-Wilson GJ; Arronet GH
    Int J Fertil; 1977; 22(4):225-31. PubMed ID: 24600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
    Tulandi T; McInnes RA; Arronet GH
    Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A simplified quick semi-quantitative determination of urinary estrogen in non-pregnant female: the application for monitoring of follicular maturation at HMG-HCG therapy].
    Kamata S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):64-72. PubMed ID: 3081668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of multiple gestations following hMG-hCG therapy by ultrasonography and midluteal phase progesterone determinations.
    Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K; Mizoe J
    Int J Fertil; 1983; 28(3):184-7. PubMed ID: 6140241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of ovulation and pregnancy in twenty-six patients with primary hypogonadotropic amenorrhea.
    Batrinos ML; Panitsa-Faflia C
    Int J Fertil; 1980; 25(4):257-66. PubMed ID: 6114047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal requirements for a successful outcome in anovulatory patients treated with human menopausal gonadotropins.
    Sallam HN; Sallam AN; Ezzeldin FE; Agamia AF; Abou-Ali AH
    Int J Fertil Womens Med; 2000; 45(4):285-91. PubMed ID: 10997485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The plasma and urinary hormone profiles during treatment with human gonadotrophins (author's transl)].
    Salat-Baroux J; Scemama-Kestenberg H
    J Gynecol Obstet Biol Reprod (Paris); 1978; 7(7):1269-90. PubMed ID: 744868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of growth hormone (GH), GH-receptor and GH-binding protein in reproduction and ovulation induction.
    Blumenfeld Z; Amit T
    J Pediatr Endocrinol Metab; 1996; 9(2):145-62. PubMed ID: 8887137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of various therapies for the luteinized unruptured follicle syndrome.
    Check JH; Dietterich C; Nowroozi K; Wu CH
    Int J Fertil; 1992; 37(1):33-40. PubMed ID: 1348733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.